FORA Capital’s bluebird bio BLUE Stock Holding History

FORA Capital’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-669	Closed	-$277K	–	420
2021 Q2	$277K	Buy	+669	New	+$265K	0.05%	369
2021 Q1	–	Sell	-316	Closed	-$177K	–	789
2020 Q4	$177K	Buy	+316	New	+$200K	0.03%	537

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

FORA Capital's BLUE Position: Q3 2021 in Review

FORA Capital sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 669 shares — an estimated $277K sold.

FORA Capital first reported a position in BLUE in Q4 2020 and held it in 2 quarters. The position peaked at $277K in Q2 2021. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

FORA Capital reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 669 bluebird bio shares in Q3 2021, an estimated $277K.
FORA Capital first reported a position in bluebird bio in Q4 2020 and held it in 2 quarters.
FORA Capital's bluebird bio position peaked at $277K in Q2 2021.
196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.